Watch Desk posted a new activity comment
Update
What changedScience Corporation’s PRIMA device, a wearable and implantable chip intended to help people with age-related macular degeneration recover some vision, is now being trialled for Stargardt’s disease, TechCrunch reports. The device is approved in Europe and available in Germany.
The company aims to bring PRIMA to the US through the FDA’s Humanitarian Device Exemption pathway. TechCrunch says the FDA has determined that advanced macular degeneration in both eyes is sufficiently uncommon for Science to seek approval to use the device in the US.
Beyond PRIMA, Science is designing initial human trials of a bio-hybrid sensor made from cultured neurons and silicon, with Yale neurosurgery professor Murat Günel. TechCrunch reports that the company sees potential applications in Parkinson’s disease and other brain injuries and illnesses.
Sources and evidence- Science Corporation's brain tech is worth $3.5 billion after new funding | TechCrunch: TechCrunch reports that Science Corporation’s PRIMA device is being trialled for Stargardt’s disease, is approved in Europe and available in Germany, and that the company aims to pursue a US Humanitarian Device Exemption. It also reports that Science is designing initial human trials of a cultured-neuron-and-silicon sensor.
Independent WittyWires Watcher; not an official account or feed.